Summary
In this study we investigated the direct, shortterm effects of human growth hormone (hGH) on the biology of normal adult human osteoblast-like (hOB) cells cultured from trabecular bone explants. In Subconfluent cultures, hGH stimulated hOB proliferation in a dose-dependent fashion (P<0.001, n=15) with half-maximal effects at a concentration of 10 ng/ml. These mitogenic effects were detectable within 24 hours as shown by bromodeoxyuridine labeling. In confluent cultures containing mainly quiescent cells, hGH increased levels of alkaline phosphatase (P<0.05, n=10) and to a lesser degree levels of procollagen type I carboxyterminal propeptide (PICP) (P=0.07, n=9). Effects on osteocalcin (bone GLa protein, BGP) levels were highly variable among different cell strains and only 7 of 10 cell strains showed a stimulatory response (P=0.16). We also studied the effects of hGH on osteoblastic production of insulin-like growth factor I (IGF-I) and IGF-II as well as the production of GH-dependent, insulin-like growth factor binding protein 3 (IGFBP-3). Under basal conditions, human osteoblasts produced IGF-II and IGFBP-3 in the conditioned medium. When stimulated with hGH, minor insignificant increase in both IGF-II and IGFBP-3 (125% and 126% of control, respectively) were detectable. No IGF-I was detectable in the conditioned medium under basal conditions or after stimulation with hGH. In conclusion, the results obtained in this study suggest that GH exerts direct anabolic effects on human osteoblasts.
Similar content being viewed by others
References
Isaksson OG, Lindhal A, Nilsson A, Isgaard J (1987) Mechanisms of the stimulatory effects of growth hormone on longitudinal bone growth. Endocr Rev 8:426–438
Russell SM, Spencer EM (1985) Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. Endocrinology 116:2563–2568
Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A (1990) A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 5:609–618
Marcus R, Butterfield G, Holloway L, Baylink DJ, Hintz RL, Sherman BM (1990) Effects of short-term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70:519–527
Slootweg MC, Buul-Offers SC, Herrmann-Erlee MPM, Meer JM, Duursma SA (1988) Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. Endocrinology 116:11–13
Ernst M, Froesch ER (1988) Growth hormone-dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor 1. Biochim Biophys Res Commun 151:142–147
Maor G, Hochberg Z, Mark K, Heinegard D, Silbermann M (1989) Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 125:1239–1245
Scheven BAA, Hamilton NJ, Fakkeldij TMV, Duursma SA (1991) Effects of recombinant human insulin-like growth factor I and II (IGF-I/II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regulation 1:160–167
Chenu C, Valentin-Optan A, Chavassieux P, Saez S, Meunier PJ, Delmas PD (1990) Insulin-like growth factor 1 hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures Bone 11:81–86
Daughaday WH, Rotwein P (1989) Insulin-like growth factors I and II peptide, messenger ribonucleic acid and gene structure, serum and tissue concentrations. Endocr Rev 10:68–91
Canalis E, McCarthy TL, Centrella M (1989) The role of skeletal growth factors in skeletal remodeling. Endocrinol Metab Clin N Am 18:903–918
Wergedal JE, Mohan S, Lundy M, Baylink DJ (1990) Skeletal growth factors and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 5:179–186
Hassager C, Spencer EM, Fitzpatrick LA, Riggs BL (1991) Insulin-like growth factor binding protein secretion in osteoblast-like cells is cell line specific. J Bone Miner Res 6(suppl 1): s146
Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR (1990) A specific radioimmunoassay for the growth hormone(GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292–1298
Baxter RC, Martin JL (1989) Binding proteins for the insulin-like growth factors: structure, regulation and function Prog Growth Factor Res 1:49–68
Robey PG, Termine JD (1985) Human bone cells in vitro. Calcif Tissue Int 37:453–460
Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84–86
Egsmose C, Daugaard H, Lund B, (1989) Determination of bone Gla protein (osteocalcin) by enzyme-linked immunosorbent assay. Clin Chim Acta 184:279–288
Melkko J, Niemi S, Risteli L, Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328–1332
Risteli J, Niemi S, Trivedi P, Maentausta O, Mowat OP, Risteli L (1988) Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 34:715–718
Blum WF, Ranke MB, Bierich JR (1988) A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. Acta Endocrinol 118:374–380
Blum WF, Breier B, Gluckman P, Ranke MB (1992) A novel IGFBP-blocked IGF-I RIA that measured what it pretends to measure: IGF-I. Acta Endocrinol 126 (suppl 4):76
Feldman HA (1988) Families of lines: random effects in linear regression analysis. J Appl Physiol 64:1721–1732
Cook JJ, Haynes KM, Werther GA (1988) Mitogenic effects of growth hormone in cultured human fibroblasts. J Clin Invest 81:206–212
Brixen K, Risteli J, Risteli L, Nielsen HK, Flyvbjerg A, Eriksen EF, Mosekilde L (1992) Effects of short course of growth hormone treatment on type I and type III procollagen propeptides in serum in normal human volunteers. Eur J Exp Musculoskel Res 1:5–10
Rodan GA, Rodan SB (1983) Expression of the osteoblastic phenotype, In: Peck WA (ed) Bone and mineral research, annual 1. Elsevier, Amsterdam, p 244
Mohan S, Bautista CM, Herring SJ, Linkhart TA, Baylink D (1990) Development of valid methods to measure insulin-like growth factors-I and-II in bone cell-conditioned medium. Endocrinology 126:2534–2542
Mohan S, Jennings JC, Linkhart TA, Baylink D (1988) Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta 966:44–55
Mohan S, Dequeker J, Van den Eyned R, Peeters J, Aerssens J, Baylink D (1991) Increased IGF-I and IGF-II in bone from patients with osteoarthritis. J Bone Miner Res 6(suppl 1): s131
Slootweg MC, Vangenesen ST, Otte AP, Duursma SA, Kruijer W (1990) Activation of mouse osteoblast growth hormone receptor. C-fos oncogene expression expression independent of phosphoinositide breakdown and cyclic AMP. J Mol Endocrinol 4:265–274
Murphy LJ, Bell GI, Friesen HG (1987) Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo. Endocrinology 120:1806–1812
Barnard R, Ng NW, Martin TJ, Waters MJ (1991) Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 128:1459–1464
Green H, Morikawa M, Nixon T (1985) A dual effector theory of growth-hormone action. Differentiation 29:195–198
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kassem, M., Blum, W., Ristelli, J. et al. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro . Calcif Tissue Int 52, 222–226 (1993). https://doi.org/10.1007/BF00298723
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00298723